Surgical decompression, with or without adjunctive therapy, for palliative treatment of primary vertebral osteosarcoma in dogs.


Journal

Veterinary and comparative oncology
ISSN: 1476-5829
Titre abrégé: Vet Comp Oncol
Pays: England
ID NLM: 101185242

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 04 10 2018
revised: 08 05 2019
accepted: 09 05 2019
pubmed: 18 5 2019
medline: 7 3 2020
entrez: 18 5 2019
Statut: ppublish

Résumé

Vertebral osteosarcoma (OSA) is the most common primary vertebral tumor in dogs, however studies examining the survival time after surgical decompression of these tumors are limited. There is also limited information regarding the benefit of adjunctive treatments such as radiation therapy or chemotherapy in these patients. The goal of this study was to determine survival time of dogs with primary vertebral OSA after palliative decompressive surgery alone and combined with radiation therapy and/or chemotherapy. Records from 22 client-owned dogs diagnosed with primary vertebral OSA and treated with decompressive surgery were collected retrospectively from eight referral institutions. Survival time was assessed for dogs treated with surgery alone as well as dogs who received adjunctive radiation therapy and/or chemotherapy. Median survival time in the 12 dogs treated with surgery alone was 42 days (range: 3-1333 days). The three dogs treated with surgery and chemotherapy had a median survival time of 82 days (range: 56-305 days). Only one dog was treated with surgery and radiation therapy; this dog survived 101 days. Six dogs were treated with surgery, radiation therapy and chemotherapy; these dogs had a median survival time of 261 days (range: 223-653 days). Cause of death in all cases that survived the initial postoperative period was euthanasia secondary to confirmed or suspected tumor regrowth. The results of this study suggest that definitive radiation therapy, possibly combined with concurrent chemotherapy, significantly improves survival in dogs treated with palliative decompressive surgery for vertebral OSA and should be the treatment of choice in selected cases.

Identifiants

pubmed: 31099165
doi: 10.1111/vco.12508
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

472-478

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Références

Szewczyk M, Lechowski R, Zabielska K. What do we know about canine osteosarcoma treatment?-review. Vet Res Commun. 2015;39:61-67.
Boerman I, Selvarajah GT, Nielen M, Kirpensteijn J. Prognostic factors in canine appendicular osteosarcoma-a meta analysis. BMC Vet Res. 2012;8:56.
Heyman SJ, Dieffenderfer DL, Goldschmidt MH. Canine axial skeletal osteosarcoma a retrospective study of 116 cases (1986-1989). Vet Surg. 1992;21:304-309.
Chen R, de Lorimier LP. Update on the biology and management of canine osteosarcoma. Vet Clin North Am Small Anim Pract. 2003;33:491-516.
Dickerson ME, Page RL, LaDue TA, et al. Retrospective analysis of axial skeleton osteosarcoma in 22 large-breed dogs. J Vet Intern Med. 2001;15:120-124.
Morgan JP, Ackerman N, Bailey CS, et al. Vertebral tumors in the dog: a clinical radiologic and pathologic study of 61 primary and secondary lesions. Vet Radiol Ultrasound. 1980;21:197-212.
Levy MS, Kapatkin AS, Patnaik AK, Mauldin GN, Mauldin GE. Spinal tumors in 37 dogs: clinical outcome and long term survival (1987-1994). J Am Anim Hosp Assoc. 1997;33:307-312.
Dernell WS, Van Vechten BJ, Straw RC, et al. Outcome following treatment of vertebral tumors in 20 dogs (1986-1995). J Am Anim Hosp Assoc. 2000;36:245-251.
Besalti O, Caliskan M, Can P, Vural SA, Algin O, Ahlat O. Imaging and surgical outcomes of spinal tumors in 18 dogs and one cat. J Vet Sci. 2016;17:225-234.
Levine GJ, Levine JM, Budke CM, et al. Description and repeatability of a newly developed spinal cord injury scale for dogs. Prev Vet Med. 2009;89:121-127.
Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine: terminology and surgical staging. Spine. 1997;22:1036-1044.
Fridley J, Gokaslan ZL. The evolution of surgical management for vertebral column tumors. J Neurosurg Spine. 2019;30:417-423.
Shankar GM, Clarke MJ, Ailon T, et al. The role of revision surgery and adjunctive therapy following subtotal resection of osteosarcoma of the spine: a systematic review with meta-analysis. J Neurosurg Spine. 2017;27:97-104.
Shimizu T, Murakami H, Demura S, et al. Total en bloc spondylectomy for primary tumors of the lumbar spine. Medicine. 2018;97(37):e12366.
Chauvet AE, Hogge GS, Sandin JA, Lipsitz D. Vertebrectomy, bone allograft fusion and antitumor vaccination for the treatment of vertebral fibrosarcoma in a dog. Vet Surg. 1999;28:480-488.
Walter CU, Dernell WS, LaRue SM, et al. Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease. Vet Comp Oncol. 2005;3:1-7.
Coomer A, Farese J, Milner R, Liptak J, Bacon N, Lurie D. Radiation therapy for canine appendicular osteosarcoma. Vet Comp Oncol. 2009;7:15-27.
Swift KE, LaRue SM. Outcome of 9 dogs treated with stereotactic radiation therapy for primary or metastatic vertebral osteosarcoma. Vet Comp Oncol. 2018;16:E152-E158.

Auteurs

Alexandra Dixon (A)

Department of Veterinary Clinical Sciences, Washington State University College of Veterinary Medicine, Pullman, Washington.

Annie Chen (A)

Department of Veterinary Clinical Sciences, Washington State University College of Veterinary Medicine, Pullman, Washington.

John H Rossmeisl (JH)

Department of Small Animal Clinical Sciences, Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia.

Beverly Sturges (B)

Department of Surgical and Radiological Sciences, University of California Davis School of Veterinary Medicine, Davis, California.

Karen Vernau (K)

Department of Surgical and Radiological Sciences, University of California Davis School of Veterinary Medicine, Davis, California.

Jonathan M Levine (JM)

Department of Small Animal Clinical Sciences, Texas A&M University College of Veterinary Medicine, College Station, Texas.

Arturo Otamendi (A)

Department of Small Animal Clinical Sciences, Texas A&M University College of Veterinary Medicine, College Station, Texas.

Peter Early (P)

Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina.

Alix Partnow (A)

Department of Surgical Neurology, Veterinary Specialty Center of Seattle, Lynnwood, Washington.

Lara Curtis (L)

Department of Surgical Neurology, Veterinary Specialty Center of Seattle, Lynnwood, Washington.

Stephanie Thomovsky (S)

Department of Veterinary Clinical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, Indiana.

Rebecca A Packer (RA)

Department of Clinical Sciences, Colorado State University College of Veterinary Medicine and Biomedical Sciences, Fort Collins, Colorado.

Daniela A Mauler (DA)

Department of Veterinary Medicine and Surgery, University of Missouri College of Veterinary Medicine, Columbia, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Classifications MeSH